DK2301541T3 - Antibiotiske sammensætninger til behandling af øjet - Google Patents

Antibiotiske sammensætninger til behandling af øjet

Info

Publication number: DK2301541T3
Authority: DK; Denmark
Prior art keywords: treat; eye; antibiotic compositions; antibiotic; compositions
Prior art date: 1998-09-30

Application number

DK10178657.2T

Other languages

English (en)

Inventor

Gerald Cagle

Robert L Abshire

David W Stroman

John M Yanni

Original Assignee

Alcon Pharmaceuticals Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-30

Filing date

1999-09-29

Publication date

2014-09-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26799441&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2301541(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-09-29 Application filed by Alcon Pharmaceuticals Ltd filed Critical Alcon Pharmaceuticals Ltd

2014-09-01 Application granted granted Critical

2014-09-01 Publication of DK2301541T3 publication Critical patent/DK2301541T3/da

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Otolaryngology (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DK10178657.2T 1998-09-30 1999-09-29 Antibiotiske sammensætninger til behandling af øjet DK2301541T3 (da)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US10250498P	1998-09-30	1998-09-30
US10250698P	1998-09-30	1998-09-30
EP03020587A EP1384478B1 (en)	1998-09-30	1999-09-29	Antibiotic compositions containing moxifloxacin for treatment of the eye

Publications (1)

Publication Number	Publication Date
DK2301541T3 true DK2301541T3 (da)	2014-09-01

Family

ID=26799441

Family Applications (5)

Application Number	Title	Priority Date	Filing Date
DK03020587.6T DK1384478T3 (da)	1998-09-30	1999-09-29	Antibiotiske sammensætninger indeholdende moxifloxacin til behandling af øjet
DK10176412.4T DK2269602T3 (da)	1998-09-30	1999-09-29	Antibiotiske sammensætninger til behandling af øret
DK10178657.2T DK2301541T3 (da)	1998-09-30	1999-09-29	Antibiotiske sammensætninger til behandling af øjet
DK99956504T DK1117401T3 (da)	1998-09-30	1999-09-29	Antibiotisk præparat til øjenbehandling
DK14176366.4T DK2796138T3 (da)	1998-09-30	1999-09-29	Antibiotiske sammensætninger til behandling af Conjunctivitis

Family Applications Before (2)

Application Number	Title	Priority Date	Filing Date
DK03020587.6T DK1384478T3 (da)	1998-09-30	1999-09-29	Antibiotiske sammensætninger indeholdende moxifloxacin til behandling af øjet
DK10176412.4T DK2269602T3 (da)	1998-09-30	1999-09-29	Antibiotiske sammensætninger til behandling af øret

Family Applications After (2)

Application Number	Title	Priority Date	Filing Date
DK99956504T DK1117401T3 (da)	1998-09-30	1999-09-29	Antibiotisk præparat til øjenbehandling
DK14176366.4T DK2796138T3 (da)	1998-09-30	1999-09-29	Antibiotiske sammensætninger til behandling af Conjunctivitis

Country Status (18)

Country	Link
EP (5)	EP2301541B1 (da)
JP (5)	JP2002525317A (da)
KR (1)	KR101463243B1 (da)
CN (2)	CN100374114C (da)
AR (2)	AR020661A1 (da)
AT (2)	ATE254458T1 (da)
AU (1)	AU762827B2 (da)
BR (1)	BRPI9914151B1 (da)
CA (3)	CA2659064A1 (da)
CY (3)	CY1111404T1 (da)
DE (2)	DE69943287D1 (da)
DK (5)	DK1384478T3 (da)
ES (4)	ES2519190T3 (da)
HK (1)	HK1038691B (da)
PT (5)	PT1384478E (da)
TR (2)	TR200100883T2 (da)
TW (1)	TWI222361B (da)
WO (1)	WO2000018386A2 (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6509327B1 (en)	1998-09-30	2003-01-21	Alcon Manufacturing, Ltd.	Compositions and methods for treating otic, ophthalmic and nasal infections
US6395746B1 (en)	1998-09-30	2002-05-28	Alcon Manufacturing, Ltd.	Methods of treating ophthalmic, otic and nasal infections and attendant inflammation
US6716830B2 (en)	1998-09-30	2004-04-06	Alcon, Inc.	Ophthalmic antibiotic compositions containing moxifloxacin
AR020661A1 (es)	1998-09-30	2002-05-22	Alcon Lab Inc	Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
DE19937115A1 (de)	1999-08-06	2001-02-08	Bayer Ag	Wäßrige Arzneimittelformulierung von Moxifloxacin oder Salzen davon
DE19937116A1 (de)	1999-08-06	2001-02-08	Bayer Ag	Moxifloxacin Kochsalzformulierung
EP1214056B1 (en)	1999-09-24	2003-10-29	Alcon Inc.	Topical suspension formulations containing ciprofloxacin and dexamethasone
DE19962470A1 (de) *	1999-12-22	2001-07-12	Schulz Hans Herrmann	Verwendung von Chemotherapeutika
AU2001261748A1 (en) *	2000-05-19	2001-12-03	Alcon Laboratories Inc.	Antibiotic compositions for treatment of the eye, ear and nose
WO2002007704A2 (en)	2000-07-26	2002-01-31	Alcon Universal Ltd.	Improved process for manufacturing compositions containing ciprofloxacin and hydrocortisone
WO2002040028A1 (fr) *	2000-11-16	2002-05-23	Wakamoto Pharmaceutical Co., Ltd.	Gouttes pour les yeux en gel antibacterien
WO2002049633A2 (en)	2000-12-20	2002-06-27	Alcon, Inc.	Use of amidoamines to treat or prevent acanthamoeba and fungal infections
WO2002049627A2 (en) *	2000-12-20	2002-06-27	Alcon, Inc.	Antifungal compositions containing an antibiotic and one or more amidoamines
BR0212898A (pt)	2001-09-21	2004-10-13	Alcon Inc	Método de tratamento de infecções do ouvido médio
US7220431B2 (en)	2002-11-27	2007-05-22	Regents Of The University Of Minnesota	Methods and compositions for applying pharmacologic agents to the ear
SG144936A1 (en)	2003-09-10	2008-08-28	Kyorin Seiyaku Kk	7-(4-substituted-3-cyclopropylaminomethyl-1- pyrrolidinyl)quinolonecarboxylic acid derivative
WO2006015545A1 (fr) *	2004-08-11	2006-02-16	Shenzhen Tys R & D Co., Ltd.	Capsule de gelatine de moxifloxacin et procede pour sa preparation
MX2007002462A (es) *	2004-09-03	2007-10-10	Piedmont Pharmaceuticals Llc	Metodo para el tratamiento de transmembrana y prevencion de la otitis media.
DE102005055385A1 (de) *	2004-12-09	2006-06-14	Bayer Healthcare Ag	Arzneimittel zur hygienischen Applikation im Ohr
ZA200704775B (en) *	2004-12-10	2008-08-27	Alcon Inc	Compositions for treatment of ear infections
CN101317847B (zh) *	2007-06-06	2010-10-13	深圳市瑞谷医药技术有限公司	一种眼用或耳鼻用药物组合物及其用途
TWI544934B (zh)	2008-06-09	2016-08-11	愛爾康研究有限公司	含有氟喹諾酮抗生素藥物之經改良藥學組成物
CA2765852C (en) *	2009-07-02	2014-08-26	Alcon Research, Ltd.	Compositions comprising finafloxacin and methods for treating ophthalmic, otic, or nasal infections
KR20180027611A (ko) *	2010-01-07	2018-03-14	리전츠 오브 더 유니버스티 오브 미네소타	목시플록사신을 귀에 도포하기 위한 방법 및 조성물
BR112014012885A2 (pt)	2011-12-06	2017-06-13	Alcon Res Ltd	composição de gel celulósica com estabilidade de viscosidade aperfeiçoada
RU2472507C1 (ru) *	2012-02-01	2013-01-20	Закрытое акционерное общество "Брынцалов-А"	Водный состав на основе моксифлоксацина для парентерального введения
US9504691B2 (en)	2012-12-06	2016-11-29	Alcon Research, Ltd.	Finafloxacin suspension compositions
US20150164882A1 (en)	2013-07-22	2015-06-18	Imprimis Pharmaceuticals, Inc.	Pharmaceutical compositions for intraocular administration and methods for fabricating thereof
US20160279055A1 (en)	2013-07-22	2016-09-29	Imprimis Pharmaceuticals, Inc.	Pharmaceutical ophthalmic compositions for intraocular administration and methods for fabricating thereof
CN104224802B (zh) *	2014-09-19	2017-12-12	南京优科生物医药研究有限公司	一种盐酸莫西沙星滴耳剂及其制备方法
RU2595837C2 (ru) *	2014-09-29	2016-08-27	Открытое Акционерное Общество "Татхимфармпрепараты"	Состав и способ получения глазных капель
CN108348516B (zh) *	2015-10-29	2021-02-12	特一华制药株式会社	外用剂
US12042500B2 (en) *	2018-04-03	2024-07-23	Hyderabad Eye Research Foundation	Mucoadhesive drug delivery system for ocular administration of fluoroquinolone antibiotics
IT201900005280A1 (it) *	2019-04-05	2020-10-05	Ntc S R L	Composizione otologica
EP4164625A1 (en) *	2020-06-10	2023-04-19	Ocular Science, Inc.	Compositions and uses in method for post-operative ocular care
CN116270662A (zh) *	2021-12-03	2023-06-23	苏州欧康维视生物科技有限公司	盐酸莫西沙星地塞米松磷酸钠滴眼液
KR102656260B1 (ko)	2022-10-14	2024-04-09	주식회사태준제약	목시플록사신을 포함하는 안과용 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5223493A (en)	1984-12-28	1993-06-29	Alcon Laboratories, Inc.	Anti-inflammatory compounds for ophthalmic use
CA1325382C (en) *	1988-01-27	1993-12-21	Takahiro Ogawa	Locally administrable therapeutic composition for inflammatory disease
DE3906365A1 (de) *	1988-07-15	1990-01-18	Bayer Ag	7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe
WO1990001933A1 (en) *	1988-08-26	1990-03-08	Alcon Laboratories, Inc.	Combination of quinolone antibiotics and steroids for topical ophthalmic use
JPH085779B2 (ja) *	1989-09-22	1996-01-24	杏林製薬株式会社	フレロキサシン点眼液
JPH03109236A (ja) *	1989-09-22	1991-05-09	Hoya Corp	半導体超微粒子分散ガラスの製造方法
TW209865B (da) *	1992-01-10	1993-07-21	Bayer Ag
DK0639070T4 (da)	1992-05-06	2010-12-13	Alcon Lab Inc	Anvendelse af borat-polyolkomplekser til ophtalmiske præparater
DE4424369A1 (de) *	1994-07-11	1996-01-18	Bayer Ag	Pyrido[3,2,1.i,j][3,1]benzoxazinderivate
JPH0892241A (ja) *	1994-09-22	1996-04-09	Ss Pharmaceut Co Ltd	５−ヒドラジノキノロンカルボン酸誘導体及びこれを有効成分とする抗菌剤
US5631287A (en)	1994-12-22	1997-05-20	Alcon Laboratories, Inc.	Storage-stable prostaglandin compositions
ES2173287T3 (es) *	1995-06-06	2002-10-16	Bayer Ag	Composiciones oticas antibacterianas no irritantes, no sensibilizantes y no ototoxicas.
JP3290914B2 (ja) *	1997-03-17	2002-06-10	参天製薬株式会社	眼組織におけるキノロン系抗菌剤の定量装置
WO1999015172A1 (de) *	1997-09-25	1999-04-01	Bayer Aktiengesellschaft	Arzneimittelformulierung mit kontrollierter wirkstofffreisetzung
CA2342976A1 (en)	1998-09-23	2000-03-30	Unilever Plc	Oral care compositions
AR020661A1 (es)	1998-09-30	2002-05-22	Alcon Lab Inc	Una composicion farmaceutica topica oftalmica, otica o nasal y el uso de la misma para la manufactura de un medicamento
US20020001617A1 (en) *	2000-05-26	2002-01-03	Chang-Hyun Lee	Rapidly disintegrating tablet and process for the manufacture thereof

1999
- 1999-09-27 AR ARP990104866A patent/AR020661A1/es not_active Application Discontinuation
- 1999-09-29 DE DE69943287T patent/DE69943287D1/de not_active Expired - Lifetime
- 1999-09-29 EP EP10178657.2A patent/EP2301541B1/en not_active Expired - Lifetime
- 1999-09-29 PT PT03020587T patent/PT1384478E/pt unknown
- 1999-09-29 DK DK03020587.6T patent/DK1384478T3/da active
- 1999-09-29 DK DK10176412.4T patent/DK2269602T3/da active
- 1999-09-29 CA CA002659064A patent/CA2659064A1/en not_active Abandoned
- 1999-09-29 DE DE69912972T patent/DE69912972T2/de not_active Revoked
- 1999-09-29 PT PT101764124T patent/PT2269602E/pt unknown
- 1999-09-29 EP EP99956504A patent/EP1117401B1/en not_active Revoked
- 1999-09-29 PT PT101786572T patent/PT2301541E/pt unknown
- 1999-09-29 CA CA002342211A patent/CA2342211C/en not_active Expired - Lifetime
- 1999-09-29 PT PT99956504T patent/PT1117401E/pt unknown
- 1999-09-29 ES ES10178657.2T patent/ES2519190T3/es not_active Expired - Lifetime
- 1999-09-29 ES ES99956504T patent/ES2207307T3/es not_active Expired - Lifetime
- 1999-09-29 KR KR1020017003377A patent/KR101463243B1/ko not_active Expired - Lifetime
- 1999-09-29 DK DK10178657.2T patent/DK2301541T3/da active
- 1999-09-29 BR BRPI9914151-5A patent/BRPI9914151B1/pt not_active IP Right Cessation
- 1999-09-29 TR TR2001/00883T patent/TR200100883T2/xx unknown
- 1999-09-29 CA CA2774207A patent/CA2774207A1/en not_active Abandoned
- 1999-09-29 WO PCT/US1999/022622 patent/WO2000018386A2/en not_active Ceased
- 1999-09-29 AT AT99956504T patent/ATE254458T1/de not_active IP Right Cessation
- 1999-09-29 PT PT141763664T patent/PT2796138T/pt unknown
- 1999-09-29 JP JP2000571905A patent/JP2002525317A/ja active Pending
- 1999-09-29 HK HK02100003.3A patent/HK1038691B/en not_active IP Right Cessation
- 1999-09-29 ES ES10176412.4T patent/ES2526521T3/es not_active Expired - Lifetime
- 1999-09-29 AU AU13101/00A patent/AU762827B2/en not_active Expired
- 1999-09-29 EP EP03020587A patent/EP1384478B1/en not_active Expired - Lifetime
- 1999-09-29 DK DK99956504T patent/DK1117401T3/da active
- 1999-09-29 AT AT03020587T patent/ATE501732T1/de active
- 1999-09-29 CN CNB2004100973271A patent/CN100374114C/zh not_active Expired - Lifetime
- 1999-09-29 DK DK14176366.4T patent/DK2796138T3/da active
- 1999-09-29 CN CNB998115096A patent/CN1184968C/zh not_active Ceased
- 1999-09-29 TR TR2007/04370T patent/TR200704370T2/xx unknown
- 1999-09-29 EP EP10176412.4A patent/EP2269602B1/en not_active Expired - Lifetime
- 1999-09-29 ES ES14176366.4T patent/ES2602956T3/es not_active Expired - Lifetime
- 1999-09-29 EP EP14176366.4A patent/EP2796138B1/en not_active Expired - Lifetime
- 1999-11-03 TW TW088116726A patent/TWI222361B/zh not_active IP Right Cessation
2008
- 2008-08-22 JP JP2008213954A patent/JP2009007375A/ja not_active Withdrawn
2011
- 2011-04-21 CY CY20111100409T patent/CY1111404T1/el unknown
- 2011-05-12 AR ARP110101646A patent/AR081393A2/es not_active Application Discontinuation
2012
- 2012-01-10 JP JP2012002159A patent/JP2012067141A/ja not_active Withdrawn
- 2012-11-02 JP JP2012242519A patent/JP5563041B2/ja not_active Expired - Lifetime
2014
- 2014-05-19 JP JP2014103658A patent/JP2014144982A/ja active Pending
- 2014-10-09 CY CY20141100819T patent/CY1115759T1/el unknown
2015
- 2015-01-09 CY CY20151100023T patent/CY1115916T1/el unknown

Also Published As

Publication number	Publication date
ATE501732T1 (de)	2011-04-15
EP2796138A1 (en)	2014-10-29
PT2301541E (pt)	2014-10-29
CA2342211A1 (en)	2000-04-06
CA2774207A1 (en)	2000-04-06
DE69912972D1 (de)	2003-12-24
JP2012067141A (ja)	2012-04-05
HK1150769A1 (en)	2012-01-13
JP2009007375A (ja)	2009-01-15
AR020661A1 (es)	2002-05-22
TR200704370T2 (tr)	2007-11-21
AR081393A2 (es)	2012-08-29
HK1059572A1 (en)	2004-07-09
CA2342211C (en)	2009-05-26
DK2796138T3 (da)	2016-12-05
ES2602956T3 (es)	2017-02-23
CA2659064A1 (en)	2000-04-06
BR9914151A (pt)	2001-06-26
JP2013018799A (ja)	2013-01-31
CN100374114C (zh)	2008-03-12
DE69912972T2 (de)	2004-04-22
CY1115759T1 (el)	2017-01-25
KR101463243B1 (ko)	2014-12-17
ATE254458T1 (de)	2003-12-15
CN1184968C (zh)	2005-01-19
DK2269602T3 (da)	2014-12-15
ES2526521T3 (es)	2015-01-13
EP1384478A1 (en)	2004-01-28
CN1320035A (zh)	2001-10-31
EP2796138B1 (en)	2016-08-17
AU1310100A (en)	2000-04-17
CY1111404T1 (el)	2015-08-05
CY1115916T1 (el)	2017-01-25
JP5563041B2 (ja)	2014-07-30
PT2796138T (pt)	2016-09-22
EP1117401A2 (en)	2001-07-25
EP1117401B1 (en)	2003-11-19
ES2207307T3 (es)	2004-05-16
PT2269602E (pt)	2014-12-29
EP2269602A1 (en)	2011-01-05
BRPI9914151B1 (pt)	2017-10-03
DK1384478T3 (da)	2011-05-23
WO2000018386A2 (en)	2000-04-06
ES2519190T3 (es)	2014-11-06
TR200100883T2 (tr)	2001-10-22
DE69943287D1 (de)	2011-04-28
EP2301541B1 (en)	2014-08-20
PT1117401E (pt)	2004-03-31
EP1384478B1 (en)	2011-03-16
JP2014144982A (ja)	2014-08-14
HK1150756A1 (en)	2012-01-13
HK1038691A1 (en)	2002-03-28
WO2000018386A3 (en)	2000-06-08
EP2301541A1 (en)	2011-03-30
CN1650863A (zh)	2005-08-10
JP2002525317A (ja)	2002-08-13
BRPI9914151B8 (da)	2021-05-25
AU762827B2 (en)	2003-07-03
PT1384478E (pt)	2011-05-12
HK1038691B (en)	2004-04-23
TWI222361B (en)	2004-10-21
EP2269602B1 (en)	2014-11-19
DK1117401T3 (da)	2004-02-23
KR20010075138A (ko)	2001-08-09

Publication	Publication Date	Title
PT1049467E (pt)	2003-02-28	Composicoes de celecoxib
ID26549A (id)	2001-01-18	Komposisi-komposisi epotilon
ATE367793T1 (de)	2007-08-15	Schweisshemmende zusammensetzungen
ATE469550T1 (de)	2010-06-15	Antiparasitäre zusammensetzungen
FI981011L (fi)	1999-11-07	Uudet koostumukset
IS6120A (is)	2001-10-22	Lyfjablanda
AR023440A1 (es)	2002-09-04	Composiciones antitranspirantes
DE60040350D1 (de)	2008-11-06	Weichspülerzusammensetzungen
DE69919953D1 (de)	2004-10-14	Funktionelle zusammensetzungen
DE69929799D1 (de)	2006-04-20	Ultraviolettlicht absorbierende zusammensetzungen
DE69935172D1 (de)	2007-03-29	Imidosilan Zusammensetzungen
DK1117401T3 (da)	2004-02-23	Antibiotisk præparat til øjenbehandling
ID29785A (id)	2001-10-11	Komposisi-komposisi sampo
ATE257691T1 (de)	2004-01-15	Schweisshemmende zusammensetzungen
ID27889A (id)	2001-05-03	Komposisi-komposisi kopolimer polisiklik
ATE302839T1 (de)	2005-09-15	Bleichungzusammensetzungen
DE69837482D1 (de)	2007-05-16	Entschäumende zusammensetzungen
DE69943245D1 (de)	2011-04-14	Gaserzeugende zusammensetzung
NO20010873D0 (no)	2001-02-21	Mikropartikkel-blanding
DE60009934D1 (de)	2004-05-19	Glasfaserzusammensetzung
ATE296323T1 (de)	2005-06-15	Polyisocyanatzusammensetzungen
DE69916548D1 (de)	2004-05-27	Schwingungsdämpfende Zusammensetzung
DE60020682D1 (de)	2005-07-14	Resorcinenthaltende zusammensetzung
ID26295A (id)	2000-12-14	Komposisi keras-ultraviolet
ID27329A (id)	2001-03-29	Komposisi penghambat